{"id":"W2313622309","doi":"10.1136/annrheumdis-2014-eular.2283","title":"SAT0396 Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Adverse effect; Internal medicine; Concomitant; Placebo; Clinical endpoint; Randomization; Dosing; Psoriasis; Randomized controlled trial; Arthritis; Rheumatoid arthritis; Adalimumab; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004706927,0.0002140634,0.001017798,0.0001567186,0.00007157055,0.00001884786,0.0002110238,0.00004874901,0.00004799131],"category_scores_gemma":[0.001677931,0.0001322541,0.0001276228,0.0002171146,0.0001875018,0.0001553676,0.0001153396,0.0001534972,0.000004951456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001629608,"about_ca_system_score_gemma":0.0001286396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003482717,"about_ca_topic_score_gemma":0.00004947798,"domain_scores_codex":[0.99745,0.0003711352,0.0009756185,0.0002855753,0.0006584263,0.000259247],"domain_scores_gemma":[0.9976578,0.0007490831,0.000561276,0.0006523049,0.0002528414,0.000126723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8263485,0.01260651,0.03637637,0.0002595319,0.001211604,0.000003031269,0.003860706,0.00005599564,0.000005525662,0.00002401872,0.0001297841,0.1191184],"study_design_scores_gemma":[0.5133151,0.001774832,0.4804494,0.001906968,0.0002254297,1.484696e-7,0.001604119,0.0004460457,0.00008806257,0.00005482706,0.00002156115,0.0001134987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947147,0.0005211821,0.000005935933,0.0002510932,0.00003862716,0.004101576,0.0001736752,0.00001417418,0.0001790582],"genre_scores_gemma":[0.9994359,0.0002809106,0.00002462475,0.00004218457,0.00001038454,0.00008868541,0.00006363836,0.00002206766,0.00003157646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.444073,"threshold_uncertainty_score":0.5393167,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02758072766961923,"score_gpt":0.3192333291753375,"score_spread":0.2916526015057183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}